Physician profile
Gregory J Streff
NPI 1558314005
$10,259.30
in general payments reported to CMS, 2019-2025
59 companies · $973 in 2025
The $973 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $916 · 2021: $1,092 · 2022: $1,853 · 2023: $2,110 · 2024: $2,330 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,134 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,134.08 |
| Education | $279.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,514.72 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $878.79 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $673.78 | 2019-2025 | Ofev, Spiriva Respimat |
| Jazz Pharmaceuticals INC. | $636.00 | 2019-2025 | |
| Harmony Biosciences LLC | $619.42 | 2020-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $412.92 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $329.32 | 2019-2024 | Opsumit, Uptravi |
| United Therapeutics Corporation | $322.53 | 2019-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $316.48 | 2020-2024 | Glassia, Cuvitru |
| Grifols USA, LLC | $315.78 | 2021-2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $282.92 | 2019-2024 | Xarelto |
| Amgen INC. | $268.49 | 2019-2025 | Tezspire, Tavneos |
| Genzyme Corporation | $264.54 | 2021-2025 | |
| Insmed, INC. | $257.45 | 2020-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $250.59 | 2022-2025 | Verquvo, Winrevair, Keytruda |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $229.58 | 2019-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $228.73 | 2020-2023 | Acthar |
| Axsome Therapeutics, INC. | $227.22 | 2022-2025 | Sunosi |
| Philips North America LLC | $226.68 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.53 | 2019-2025 | Lifevest |
| Genentech USA, INC. | $177.25 | 2019-2023 | Xolair, Esbriet |
| Alnylam Pharmaceuticals INC. | $129.45 | 2021-2024 | Onpattro |
| Abbott Laboratories | $106.17 | 2019-2023 | Cardiomems |
| Avadel Cns Pharmaceuticals, LLC | $103.09 | 2023-2025 | Lumryz |
| Novartis Pharmaceuticals Corporation | $100.49 | 2019-2022 | |
| Resmed Corp | $95.67 | 2023-2024 | |
| Pulmonx Corporation | $91.94 | 2020-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Csl Behring | $61.84 | 2019-2025 | Hizentra |
| Inspire Medical Systems, INC. | $58.20 | 2024 | Inspire |
| Electromed, INC. | $57.02 | 2019-2025 | Smartvest |
| Pfizer INC. | $54.52 | 2020-2023 | |
| Kestra Medical Technology Services, INC. | $51.40 | 2023-2024 | Assure Wcd |
| Baxter Healthcare | $50.47 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Circassia INC. | $45.67 | 2019 | |
| Shire North American Group INC | $45.62 | 2019 | |
| Boston Scientific Corporation | $44.72 | 2021-2025 | Watchman Flx |
| Teleflex LLC | $44.01 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.86 | 2021-2023 | |
| Bracco Diagnostics INC. | $37.13 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $36.40 | 2021 | |
| Edwards Lifesciences Corporation | $35.40 | 2019-2020 | |
| Lilly USA, LLC | $35.27 | 2025 | Zepbound |
| Sunovion Pharmaceuticals INC. | $35.06 | 2019-2020 | |
| Lundbeck LLC | $33.96 | 2020 | |
| Mallinckrodt Enterprises LLC | $30.39 | 2019 | |
| Viatris Specialty LLC | $22.63 | 2025 | Yupelri |
| Scpharmaceuticals INC. | $19.00 | 2023 | |
| Hospira, INC. | $18.86 | 2024 | |
| Ani Pharmaceuticals, INC. | $18.82 | 2024 | Purified Cortrophin Gel |
| Advanced Respiratory, INC | $18.64 | 2021 | |
| Amryt Pharma Holdings LTD | $14.94 | 2022 | |
| Bardy Diagnostics, INC. | $14.59 | 2019 | |
| Amarin Pharma, INC. | $13.03 | 2019 | |
| Ekos Corporation | $12.87 | 2019 | |
| Eisai INC. | $12.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.05 | 2021 | |
| Gilead Sciences, INC. | $11.17 | 2019 | |
| Inogen, INC. | $11.13 | 2022 | |
| Veran Medical Technologies, INC. | $7.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Streff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.